Folkerth, S
Uppsala University · University of Hull · Hadassah Medical Center · Translational Research Institute for Metabolism and Diabetes · AdventHealth · University of Nebraska Medical Center · Hull York Medical School · University of Sheffield
2 papers on CoChat
Most cited papers
- Verified
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Mosenzon, O., Blicher, T. M., Rosenlund, S., Eriksson, J. W., Heller, S., Hels, O. H., Pratley, R., Sathyapalan, T., Desouza, C., Abramof, R., et al. (2019) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 351
- Verified
Efficacy, safety, and tolerability of oral semaglutide versus placebo added to insulin with or without metformin in patients with type 2 diabetes: the PIONEER 8 trial.
Zinman, B., Aroda, V. R., Buse, J. B., Cariou, B., Harris, S. B., Hoff, S. T., Pedersen, K. B., Tarp-Johansen, M. J., Araki, E., PIONEER 8 Investigators, et al. (2019) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 300
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free